| Clinical significance of medication reconciliation in children admitted to a UK pediatric hospital: observational study of neurosurgical patients. | |
| | |
MedLine Citation:
|
PMID: 20799761 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
BACKGROUND: In December 2007, the National Institute for Health and Clinical Excellence and the National Patient Safety Agency in the UK (NICE-NPSA) published guidance that recommends all adults admitted to hospital receive medication reconciliation, usually by pharmacy staff. A costing and report tool was provided indicating a resource requirement of 12.9 million pounds for England per year. Pediatric patients are excluded from this guidance. OBJECTIVE: To determine the clinical significance of medication reconciliation in children on admission to hospital. METHODS: A prospective observational study included pediatric patients admitted to a neurosurgical ward at Birmingham Children's Hospital, Birmingham, England, between September 2006 and March 2007. Medication reconciliation was conducted by a pharmacist after the admission of each of 100 consecutive eligible patients aged 4 months to 16 years. The clinical significance of prescribing disparities between pre-admission medications and initial admission medication orders was determined by an expert multidisciplinary panel and quantified using an analog scale. The main outcome measure was the clinical significance of unintentional variations between hospital admission medication orders and physician-prescribed pre-admission medication for repeat (continuing) medications. RESULTS: Initial admission medication orders for children differed from prescribed pre-admission medication in 39% of cases. Half of all resulting prescribing variations in this setting had the potential to cause moderate or severe discomfort or clinical deterioration. These results mirror findings for adults. CONCLUSIONS: The introduction of medication reconciliation in children on admission to hospital has the potential to reduce discomfort or clinical deterioration by reducing unintentional changes to repeat prescribed medication. Consequently, there is no justification for the omission of children from the NICE-NPSA guidance concerning medication reconciliation in hospitals, and costing tools should include pediatric patients. |
| | |
Authors:
|
David R P Terry; Guirish A Solanki; Anthony G Sinclair; John F Marriott; Keith A Wilson |
Publication Detail:
|
Type: Clinical Trial; Journal Article |
Journal Detail:
|
Title: Paediatric drugs Volume: 12 ISSN: 1179-2019 ISO Abbreviation: Paediatr Drugs Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-08-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883685 Medline TA: Paediatr Drugs Country: New Zealand |
Other Details:
|
Languages: eng Pagination: 331-7 Citation Subset: IM |
Affiliation:
|
Department of Pharmacy, Birmingham Children's Hospital, Birmingham, England. david.terry@bch.nhs.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ketoprofen pharmacokinetics, efficacy, and tolerability in pediatric patients.
Next Document: The role of rapid antigen testing for influenza in the era of molecular diagnostics.